FDA approves new imaging agent for Alzheimer’s disease detection
The FDA approved Tauklarify, a tau PET imaging agent, for detecting tau pathology in adults evaluated for Alzheimer’s disease.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Tauklarify